A randomized phase 2 study of abemaciclib versus docetaxel in patients with stage IV squamous cell lung cancer (SqCLC) previously treated with platinum-based chemotherapy.

被引：1
|
作者：
Scagliotti, Giorgio V.
Govindan, Ramaswamy
Hurt, Karla
Chiang, Alan
机构：
[1] Univ Turin, Turin, Italy
[2] Washington Univ, Sch Med, St Louis, MO USA
[3] Eli Lilly, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.TPS9101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS9101
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy
    Yuichi Tambo
    Yukio Hosomi
    Hiroshi Sakai
    Naoyuki Nogami
    Shinji Atagi
    Yasutsuna Sasaki
    Terufumi Kato
    Toshiaki Takahashi
    Takashi Seto
    Makoto Maemondo
    Hiroshi Nokihara
    Ryo Koyama
    Kazuhiko Nakagawa
    Tomoya Kawaguchi
    Yuta Okamura
    Osamu Nakamura
    Makoto Nishio
    Tomohide Tamura
    Investigational New Drugs, 2017, 35 : 217 - 226
  • [42] Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens
    Fossella, FV
    DeVore, R
    Kerr, RN
    Crawford, J
    Natale, RR
    Dunphy, F
    Kalman, L
    Miller, V
    Lee, JS
    Moore, M
    Gandara, D
    Karp, D
    Vokes, E
    Kris, M
    Kim, Y
    Gamza, F
    Hammershaimb, L
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (12) : 2354 - 2362
  • [43] EVALUATION OF SUBCUTANEOUS (SC) VERSUS INTRAVENOUS (IV) PALONOSETRON IN CANCER PATIENTS TREATED WITH PLATINUM-BASED CHEMOTHERAPY: A RANDOMIZED PHARMACOKINETIC ASSAY
    Arevalo, E.
    Del Barrio, A.
    Sadaba, B.
    Campanero, M. A.
    Azanza, J. R.
    Gurpide, A.
    Lopez Picazo, J. M.
    Martin Algarra, S.
    Perez Gracia, J. L.
    ANNALS OF ONCOLOGY, 2012, 23 : 508 - 509
  • [44] Thromboembolic events in lung cancer patients treated with platinum-based chemotherapy
    Rouis, Houda
    Kamoun, Hela
    Rejeb, Hadhemi
    Ben Tkhayat, Achraf
    Smadhi, Hanen
    Greb, Dorra
    Ben Abdelghaffar, Hajer
    Akrout, Ines
    Hassene, Hela
    Fekih, Leila
    Megdiche, Mohamed Lamine
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [45] Docetaxel concomitant with radiotherapy in patients with nonsmall cell lung cancer unresponsive to platinum-based induction chemotherapy
    Ozkok, S
    Yalman, D
    Goker, E
    Parvizi, M
    Cok, G
    Goksel, T
    Haydaroglu, A
    LUNG CANCER, 2005, 49 : S381 - S381
  • [46] Nivolumab Plus Ipilimumab for Previously Treated Stage IV Squamous Cell Lung Cancer
    Gil-Sierra, Manuel David
    del Pilar Briceno-Casado, Maria
    Sanchez-Hidalgo, Marina
    JAMA ONCOLOGY, 2022, 8 (04) : 641 - 642
  • [47] Phase II pharmacodynamic trial of erlotinib in advanced non-small cell lung cancer (NSCLC) patients previously treated with platinum-based chemotherapy
    Felip, E
    Rojo, F
    Heller, A
    Foernzler, D
    Majo, J
    Klughammer, B
    Ramos, J
    Maacke, H
    Brennscheidt, U
    Baselga, J
    LUNG CANCER, 2005, 49 : S369 - S369
  • [48] Carboplatin and paclitaxel in patients with non-small-cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy: A phase II study from the Niigata Lung Cancer Treatment Group
    Yoshizawa, Hirohisa
    Watanabe, Satoshi
    Tanaka, Junta
    Matsuyama, Koki
    Hirose, Takayuki
    Tanaka, Hiroshi
    Kagamu, Hiroshi
    Ito, Kazuhiko
    Maruyama, Yoshie
    Gejyo, Fumitake
    ANNALS OF ONCOLOGY, 2004, 15 : 177 - 177
  • [49] A multicenter phase II study of single-agent docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small cell lung cancer previously treated with platinum-based chemotherapy
    Papadakis, E
    Alexopoulos, K
    Androulakis, N
    Kourousis, C
    Kakolyris, S
    Samelis, G
    Patila, E
    Vossos, A
    Samantas, E
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1998, 9 : 92 - 92
  • [50] Original Research Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory to fluoropyrimidine- and platinum-based chemotherapy: OGSG1201
    Yamamoto, Sachiko
    Kawakami, Hisato
    Kii, Takayuki
    Hara, Hiroki
    Kawabata, Ryohei
    Kawada, Junji
    Takeno, Atsushi
    Matsuyama, Jin
    Ueda, Shugo
    Okita, Yoshihiro
    Endo, Shunji
    Kimura, Yutaka
    Yanagihara, Kazuhiro
    Okuno, Tatsuya
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Satoh, Taroh
    EUROPEAN JOURNAL OF CANCER, 2021, 154 : 307 - 315
12345